Special Issue "Combating Antibiotic Resistance with Precision Medicine: The Value of Diagnostic"
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (15 September 2022) | Viewed by 16326
Interests: health economics; health technologies; economic analysis models in health policies and services
2. Health Economics Research Group, University of La Rioja, La Rioja, Spain
Interests: public policy analysis; analysis of health conditions through household surveys; health policy in Latin American countries; health economics
Antimicrobial resistance (AMR) is a major public health problem. It causes a great loss of life worldwide and even threatens to reverse some important medical advances of the last century, as the World Health Organization (WHO) has recognized by declaring it one of the top ten Public Health threats facing humanity.
The inappropriate and excessive use of antimicrobials in medicine and veterinary care is the main factor that determines the appearance of drug-resistant pathogens. The most dramatic consequences of the dissemination of resistance to antibiotics are observed in the medical environment, although the problem has its origin not only in it but also in the environment, in agriculture and livestock environments, which raises the convenience to assume the “One Health” approach advocated by WHO. Thus, plans and programs to improve the prescription and use of antibiotics are necessary.
In recent years, more and more high-quality, effective and adequate diagnostic tests have been developed to guide the appropriate use of antibiotics, which are becoming more available in any setting. These techniques and equipment not only contribute to the improvement of patients' health but, in the long term, can contribute to containing the problem of AMR.
This Special Issue hopes to receive manuscripts that promote a better understanding of the value that the improvement of the diagnoses of infections, in any type and scope of care, can bring to improve the precision and personalization of prescriptions and the impact of this improvement on the containment of antimicrobial resistance. In particular, studies that expand the information available on the comparative efficiency of diagnostic procedures susceptible to alternative use are desirable.
Prof. Dr. Carmelo A. Juárez-Castelló
Prof. Dr. Marino J. González
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Antibiotic prescription and use
- Antimicrobial resistance (AMR)
- Diagnostic methods and technologies
- Precision medicine
- Stratified medicine
- Personalized medicine
- One Health